$ERAS

Erasca Inc

$ERAS

Erasca Inc

Past 12mo:16mentions2voices

All voices4 calls since Nov 2025show all

Loading price chart…

Recent calls

4 calls

@adamfeuersteinJul 15, 2026 · 7:32 PM

@pemulisking Momentum. Me-too KRAS hopium. $ERAS can selectively disclose tiny drips of “positive” data, no risk of blow up and come-to-Jesus moments are far off.

Open on X

@adamfeuersteinApr 27, 2026 · 1:31 PM

$ERAS pan-Ras data update this afternoon after market close. also, $RVMD sent Erasca a letter claiming ERAS-0015 violates certain RevMed patents. https://t.co/QTmyUhT89n

Open on X

@adamfeuersteinApr 23, 2026 · 12:19 PM

This week's Biotech Scorecard: Erasca $ERAS is the poor man's $RVMD (even tho $7B is far from impoverished) Can it be biotech's next big thing? Pan-Ras data next month, right in front of #ASCO26 abstract drop. I spoke to CEO Jon Lim... https://t.co/GckT7X7jdN

Open on X

@jacobpliethNov 19, 2025 · 10:40 AM

$ERAS David Chacko reiterating timelines for ERAS-0015 & ERAS-4001: first ph1 monorx dose-escalation data for both expected in calendar 2026 #Jefferies25

Open on X

About this stock

$ERAS was mentioned 16 times over a 12-month period from November 2025 through July 2026 by two distinct FinTwit voices, with @jacobplieth contributing 9 mentions and @adamfeuerstein contributing 7 mentions. The biotech category dominated discussion of Erasca Inc. First mention in the archive dates to November 19, 2025, with the most recent discussion on July 15, 2026.

AI-generated from tracked posts · updated Jul 16, 2026